Open AccessLupus panniculitis as an initial manifestation of systemic lupus erythematosus
Author(s) -
Ramesh Patel,
YS Marfatia
Publication year - 2010
Publication title -
indian journal of dermatology/indian journal of dermatology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.395
H-Index - 36
eISSN - 1998-3611
pISSN - 0019-5154
DOI - 10.4103/0019-5154.60364
Subject(s) - medicine , panniculitis , malar rash , dermatology , hydroxychloroquine , systemic lupus erythematosus , lupus erythematosus , systemic lupus , scalp , rash , pathology , immunology , anti nuclear antibody , disease , covid-19 , infectious disease (medical specialty) , antibody , autoantibody
In May, 2003, a 28-year-old female presented with large non-healing ulcers on face, trunk and limbs covered with black hemorrhagic crust. There were no other systemic manifestations. Diagnosis of lupus panniculitis was considered on clinical and histopathological grounds. The lesions healed completely, with scarring, with systemic corticosteroid, hydroxychloroquine and topical 2% mupirocin. She came again in November, 2005, with malar rash, joint pain, scarring alopecia of the scalp and albuminuria. Her ANA, AntidsDNA came positive and diagnosed as having systemic lupus erythematosus (SLE). She responded well to systemic corticosteroid, antimalarial and topical antibacterial. The evolution of lupus panniculitis is slow and characterized by regression of the inflammatory lesions when treated with antimalarial drugs. The lupus panniculitis generally has a favorable course.